An angel investor allocates $2.5 million across 4 biotech startups. She invests 30% in gene-editing, 25% in synthetic biology, 20% in AI-driven drug discovery, and the remainder in regenerative medicine. How much, in dollars, was invested in regenerative medicine?

An angel investor allocates $2.5 million across 4 biotech startups. She invests 30% in gene-editing, 25% in synthetic biology, 20% in AI-driven drug discovery, and the remainder in regenerative medicine. How much, in dollars, was invested in regenerative medicine?

["Angel Investor Allocates $2.5 Million Across 4 Biotech Startups: Breakdown of $2.5M Investment", "In the rapidly advancing world of biotechnology, strategic investments play a critical role in fueling innovation and transforming healthcare. Recent trends show angel investors taking calculated risks by funding early-stage life sciences companies, with a particular focus on breakthroughs such as gene editing, synthetic biology, AI-driven drug discovery, and regenerative medicine.", "A notable example involves an influential angel investor who recently committed a total of $2.5 million across four pioneering biotech startups. According to the funding allocation:", "- 30% was allocated to gene-editing, equating to $750,000\n- 25% targeted synthetic biology, totaling $625,000\n- 20% supported AI-driven drug discovery, amounting to $500,000\n- The remaining percentage — 25% — was strategically invested in regenerative medicine", "This balanced portfolio highlights the investor’s confidence in emerging biotech fields and the growing emphasis on regenerative medicine — a sector poised for exponential growth.", "Calculating the exact amount invested in regenerative medicine, we take 25% of the total $2.5 million:", "[\n0.25 \ imes 2,!500,!000 = $625,!000\n]", "Thus, $625,000 was allocated to regenerative medicine — underscoring its increasing relevance in the biotech investment landscape. This diversified approach reflects not only financial prudence but also a forward-looking commitment to transformative life science innovation.", "As gene-editing therapies and AI-powered discovery continue to evolve, regenerative medicine stands as a cornerstone for future medical breakthroughs — making this $625,000 investment a pivotal step in shaping the next era of biotechnology."]

Related Articles

Trending Articles